Tailoring Treatments Over Time

STANDARD 3

Treatment selection will vary for each individual. To navigate a life-long journey with osteoarthritis (OA), it is important to strive for confidence in self-management. However, people with OA of the hip or knee often require support to manage this chronic and evolving condition. Tailoring treatments depends on the individual’s symptoms, experiences, needs, goals, and their care plan and self-efficacy. Collaboration between clinicians of different disciplines will likely be required as an individuals OA care journey develops.

Home 9 Clinician Standards: 3. Tailoring Treatments

OVERVIEW

  • Every person’s life and OA symptoms evolve differently, their unique care plan should evolve with their needs and goals​
  • Repeated imaging is  not required  for ongoing tracking of OA, the individual’s clinical presentation and personal choices guides ongoing OA management​
  • Multi-disciplinary clinician collaboration is crucial for successful OA care​
    • If you are the  Primary Clinician  you take the lead in overseeing the care plan evolution over the individual’s lifetime and building a  network of supporting clinicians  (at the same clinic or separate organizations in the community)
    • If you are a  supporting clinician,  you are responsible for clear communication back to the Primary Clinician, clear  discharge planning, and warm hand overs​
  • Have a clear follow up plan established with the individual. Follow up to evaluate the response to a treatment, or to ‘check-in’ on OA evolution
  • It can take over three months of dedication to most conservative treatments to see results​
  • The goal is to strive to empower, engage and educate the individual to self-manage their OA

TAILORING TREATMENTS

After starting the initial care plan (Standard 2), non-surgical osteoarthritis (OA) care will continue for everyone differently. This is because every person’s life and OA will evolve differently. Tailoring of care depends on symptom evolution, experience with treatments and individual needs.

As described in Standard 2, the non-surgical OA Treatments are used to build the initial care plan. The non-surgical OA Treatments can also be used to guide tailoring of the care plan as the individual’s symptoms and needs evolve. After building the initial care plan, it becomes a living document that should be modified and updated over the individual’s lifetime.

There are no one-size-fits-all rules for how to combine treatments and tailor care for the individual with OA; clinical expertise should be combined with the individual’s goals and needs. The care team will work with the person to determine if the selected treatments are effectively managing their symptoms and improving function to meet their goals. Treatments that were once effective may become ineffective for symptom management and/or the individual’s goals. Treatments that were ineffective may become effective again if they haven’t been trialed for some time.

Modifications are appropriate when the individual asks for them or if the clinician notices a decline in the individual’s function or quality of life. Shared decision-making techniques should be employed for conversations about care plan modification.

Standard 1 provides detail on how imaging is not required for OA diagnosis and does not reliably correlate with symptoms1. 1 Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology. 2018;57(suppl_4):iv51–iv60.
Imaging is also not necessary for ongoing monitoring of OA progression2. 2 Sakellariou G, Conaghan PG, Zhang W, Bijlsma JWJ, Boyesen P, D’Agostion MA, Dohert M, Fodor D, Kloppenburg M, Miese F, Naredo E, Porcheret M, Iagnocco A. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis. Ann Rheum Dis. 2017 Sep;76(9):1484-1494. doi: 10.1136/annrheumdis-2016-210815. Epub 2017 Apr 7.
However, if symptoms progress rapidly and OA features need investigation then imaging can become important. Additionally, up to date imaging may be required to assist an orthopaedic surgeon in their surgery planning (Standard 8). A referral to a surgeon is a possible modification to a care plan but typically referral is not appropriate if at least 12 weeks of conservative treatment have not been trialed. The exception to this is if the criteria for immediate surgeon referral are met.

COLLABORATION

The clinician should work with the individual with OA to understand who the Primary Clinician for OA management is. It is beneficial when the Primary Clinician practices at the individual’s medical home and has prescribing privileges (i.e. for some Adjunct Treatments). It is through multi-disciplinary clinician collaboration, between the Primary Clinician and supporting disciplines, that the individual with OA will receive the best support for their care journey. Properly supported people are more likely to adopt treatment recommendations for a chronic and evolving condition like OA33Bowden JL, Hunter DJ, Deveza LA, Duong V, Dziedzic KS, Allen KD, et al. Core and adjunctive interventions for osteoarthritis: Efficacy and models for implementation. Nature Reviews Rheumatology. 2020;16(8):434-47..

The Primary Clinician should take the lead in:

  • Building a network of supporting clinicians as the individual with OA trials different treatments
  • Making introductions and seeking open communication (verbal or written) with the supporting clinicians to promote comprehensive and collaborative care for the individual
  • Communicating the changes in the individual’s health status and care plan to the supporting clinicians as appropriate and
  • Guiding the individual on modifying their care plan and tailoring their treatments over time

Many supporting clinicians will offer specific treatments for a structured period of time, rather than longitudinal care. Some supporting clinicians will work in a dedicated team at the same centre as a Primary Clinician, other supporting clinicians will work at separate organizations in the community. Supporting clinicians are responsible for:

  • Asking the individual with OA to identify their Primary Clinician
  • Seeking open communication (verbal or written) with the Primary Clinician throughout the treatment period, as required
  • Planning and providing a clear discharge when appropriate and
  • Providing a ‘warm hand over’ to the Primary Clinician after the treatment period

FOLLOW-UPS: PLANNING & EXECUTION

Education sessions can be delivered in verbal, written and/or virtual formats.

The purpose of follow-up appointments is to:

  1. Evaluate the response to a new treatment; and/or
  2. Monitor the evolution in symptomology and the need to modify a care plan

Similar to modifying the care plan, there is no one-size-fits-all for scheduling follow-ups. Regardless, the plan for follow-up should be clear between the individual and the clinician. Shared decision-making techniques should be used to structure the conversations about the follow-up plan and the individual with OA should be empowered to contact the clinician to change this plan whenever they have questions or a clinical concern. This form may be used to provide a record of the new follow-up plan when it is made.

Since OA is a chronic disease with no cure4, <sup4Hart DA, Werle J, Robert J, Kania-Richmond A. Long wait times for knee and hip total joint replacement in Canada: An isolated health system problem, or a symptom of a larger problem? Osteoarthritis and Cartilage Open. 2021;3(2):100141. the primary clinician will need to be in touch with the individual with OA for their lifetime. Frequency of follow-ups may vary with time, symptomology and needs of the individual. As the care plan evolves, the follow-up plan should evolve too.

SELF MANAGEMENT

The individual with OA lives with their disease every day, while clinicians, even the Primary Clinician, only briefly intersect with this journey. Throughout the OA journey, from building the initial care plan to end of life, the goal is to empower the individual to employ strategies to cope with their OA. Every Core Treatment (Standard 4, Standard 5, and Standard 6) emphasizes the principles of self-management, and Adjunct Treatment of Additional Self-Management Programs (Standard 7) provides an opportunity for more in-depth exploration of self-management techniques.

Individuals should be encouraged to record which OA treatments they have tried from the care plan and keep detailed notes on frequency, duration, changes in symptoms, and overall experience. Note: journaling can be accomplished in any format that is comfortable to the individual. Self-monitoring and evaluation should be encouraged during care planning and at follow-up visits, so individuals feel empowered and understand that they are in charge of their care journey.

Every clinician should support the individual to apply expanding OA knowledge to gain confidence in making treatment and self-management choices as symptoms change. Self-management coping strategies for OA include:

  • Priority and goal setting
  • Self-evaluation
  • Problem-solving
  • Mental health management
  • Symptom management:
    • Thermotherapies
    • Activity self-selection
  • Seeking clinician appointments as needed
TAILORING TREATMENTS
As described in Standard 2, the non-surgical OA Treatments are used to build the initial care plan. The non-surgical OA Treatments can also be used to guide tailoring of the care plan as the individual’s symptoms and needs evolve. After building the initial care plan, it becomes a living document that should be modified and updated over the individual’s lifetime.

There are no one-size-fits-all rules for how to combine treatments and tailor care for the individual with OA; clinical expertise should be combined with the individual’s goals and needs. The care team will work with the person to determine if the selected treatments are effectively managing their symptoms and improving function to meet their goals. Treatments that were once effective may become ineffective for symptom management and/or the individual’s goals. Treatments that were ineffective may become effective again if they haven’t been trialed for some time.

Modifications are appropriate when the individual asks for them or if the clinician notices a decline in the individual’s function or quality of life. Shared decision-making techniques should be employed for conversations about care plan modification.

Standard 1 provides detail on how imaging is not required for OA diagnosis and does not reliably correlate with symptoms1. 1 Wang X, Oo WM, Linklater JM. What is the role of imaging in the clinical diagnosis of osteoarthritis and disease management? Rheumatology. 2018;57(suppl_4):iv51–iv60.
Imaging is also not necessary for ongoing monitoring of OA progression2. 2 Sakellariou G, Conaghan PG, Zhang W, Bijlsma JWJ, Boyesen P, D’Agostion MA, Dohert M, Fodor D, Kloppenburg M, Miese F, Naredo E, Porcheret M, Iagnocco A. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis. Ann Rheum Dis. 2017 Sep;76(9):1484-1494. doi: 10.1136/annrheumdis-2016-210815. Epub 2017 Apr 7.
However, if symptoms progress rapidly and OA features need investigation then imaging can become important. Additionally, up to date imaging may be required to assist an orthopaedic surgeon in their surgery planning (Standard 8). A referral to a surgeon is a possible modification to a care plan but typically referral is not appropriate if at least 12 weeks of conservative treatment have not been trialed. The exception to this is if the criteria for immediate surgeon referral are met.

COLLABORATION
The clinician should work with the individual with OA to understand who the Primary Clinician for OA management is. It is beneficial when the Primary Clinician practices at the individual’s medical home and has prescribing privileges (i.e. for some Adjunct Treatments). It is through multi-disciplinary clinician collaboration, between the Primary Clinician and supporting disciplines, that the individual with OA will receive the best support for their care journey. Properly supported people are more likely to adopt treatment recommendations for a chronic and evolving condition like OA33Bowden JL, Hunter DJ, Deveza LA, Duong V, Dziedzic KS, Allen KD, et al. Core and adjunctive interventions for osteoarthritis: Efficacy and models for implementation. Nature Reviews Rheumatology. 2020;16(8):434-47..

The Primary Clinician should take the lead in:

  • Building a network of supporting clinicians as the individual with OA trials different treatments
  • Making introductions and seeking open communication (verbal or written) with the supporting clinicians to promote comprehensive and collaborative care for the individual
  • Communicating the changes in the individual’s health status and care plan to the supporting clinicians as appropriate and
  • Guiding the individual on modifying their care plan and tailoring their treatments over time

Many supporting clinicians will offer specific treatments for a structured period of time, rather than longitudinal care. Some supporting clinicians will work in a dedicated team at the same centre as a Primary Clinician, other supporting clinicians will work at separate organizations in the community. Supporting clinicians are responsible for:

  • Asking the individual with OA to identify their Primary Clinician
  • Seeking open communication (verbal or written) with the Primary Clinician throughout the treatment period, as required
  • Planning and providing a clear discharge when appropriate and
  • Providing a ‘warm hand over’ to the Primary Clinician after the treatment period
FOLLOW-UPS: PLANNING & EXECUTION
Education sessions can be delivered in verbal, written and/or virtual formats.

The purpose of follow-up appointments is to:

    1. Evaluate the response to a new treatment; and/or
    2. Monitor the evolution in symptomology and the need to modify a care plan

Similar to modifying the care plan, there is no one-size-fits-all for scheduling follow-ups. Regardless, the plan for follow-up should be clear between the individual and the clinician. Shared decision-making techniques should be used to structure the conversations about the follow-up plan and the individual with OA should be empowered to contact the clinician to change this plan whenever they have questions or a clinical concern. This form may be used to provide a record of the new follow-up plan when it is made.

Since OA is a chronic disease with no cure4, <sup4Hart DA, Werle J, Robert J, Kania-Richmond A. Long wait times for knee and hip total joint replacement in Canada: An isolated health system problem, or a symptom of a larger problem? Osteoarthritis and Cartilage Open. 2021;3(2):100141. the primary clinician will need to be in touch with the individual with OA for their lifetime. Frequency of follow-ups may vary with time, symptomology and needs of the individual. As the care plan evolves, the follow-up plan should evolve too.

SELF MANAGEMENT
The individual with OA lives with their disease every day, while clinicians, even the Primary Clinician, only briefly intersect with this journey. Throughout the OA journey, from building the initial care plan to end of life, the goal is to empower the individual to employ strategies to cope with their OA. Every Core Treatment (Standard 4, Standard 5, and Standard 6) emphasizes the principles of self-management, and Adjunct Treatment of Additional Self-Management Programs (Standard 7) provides an opportunity for more in-depth exploration of self-management techniques.

Individuals should be encouraged to record which OA treatments they have tried from the care plan and keep detailed notes on frequency, duration, changes in symptoms, and overall experience. Note: journaling can be accomplished in any format that is comfortable to the individual. Self-monitoring and evaluation should be encouraged during care planning and at follow-up visits, so individuals feel empowered and understand that they are in charge of their care journey.

Every clinician should support the individual to apply expanding OA knowledge to gain confidence in making treatment and self-management choices as symptoms change. Self-management coping strategies for OA include:

  • Priority and goal setting
  • Self-evaluation
  • Problem-solving
  • Mental health management
  • Symptom management:
    • Thermotherapies
    • Activity self-selection
  • Seeking clinician appointments as needed
Q

Shared Decision Making

Q

Alberta Referral Directory

Q

OA Self Management Toolkit

Q

Referral Between Clinicians

Q

Warm Hand Over

Q

Scheduling Follow-ups

Q

Modifying a Care Plan

Q

Discharge Planning

Q

Scheduling Follow-ups

Q

Immediate or ‘Urgent’ Referral to Orthopaedic Surgeon